Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG

Similar documents
Curraheen, Co.Cork. Disclaimer: The information contained within this policy is accurate and up-to-date at date of approval.

Why do I need to use Fentanyl Patches?

Guidance on Bulk Prescribing for Care Home Patients

Care Homes - Homely Remedies Protocol

Guidance on Bulk Prescribing for Care Home Residents

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Medication Guide Fentanyl Transdermal System, CII (fĕn tə-nĭl) Fentanyl transdermal system is:

Care homes - Homely remedies

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers Instillation of Ear Drops (Adult)

Medication Guide Fentanyl transdermal system, CII Rx Only Fentanyl transdermal system is: A strong prescription pain medicine that contains an opioid

Homely Remedies Guidance for Care Homes

Care homes - Homely remedies

Buprenorphine Patch (Transtec Patch)

ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME

INFORMATION FOR THE CONSUMER

SAFE HANDLING OF VACCINES

ADMINISTRATION OF INSULIN

Patient Information. Sancuso [san-koo-so] (granisetron transdermal system)

Caring for your indwelling urinary catheter

University College Hospital at Westmoreland Street. Urinary sheaths. Urology Directorate

GENERIC MEDICINES (Non-Innovator Brand) PRESCRIBING POLICY

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Assisting a Service User to use an Inhaler (Adult)

Patient information. How to use your Fluorouracil 5FU 1% Eye Drops St Paul s Eye Unit PIF 539 V6

Prescription only medicines (POMs)

Opioid Type Pain Killers

Opioids in Palliative Care

Long Term Care Formulary HCD - 08

HOW TO USE YOUR INSTANYL MULTI-DOSE NASAL SPRAY

APPENDIX 1 PROCEDURES FOR ADMINISTERING MEDICATION

PATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system)

DUTRAN Transdermal Drug Delivery System

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

Lidocaine Hydrochloride BP 2% w/v in Lutrol F127 24% w/v Sterile Gel. Information for patients Pharmacy

Good Practice Guidance on Covert Administration of Medication

Q&A: Opioid Prescribing for Chronic Non-Malignant Pain

Disclosure. Being a medical caregiver means putting your self in suffering s way. Prescribing opioids The pain that won t go away

My Urinary Catheter Passport Looking after my urinary catheter

Urinary Catheter Passport SAMPLE COPY. A guide to looking after a urinary catheter. (for service users and healthcare workers) 2nd Edition

Sorafenib (Nexavar ) ( sor-af-e-nib )

Jylamvo 2 mg/ml oral solution (Methotrexate) Guide for Healthcare Professionals. Information to minimise the risk of medication error

HOW TO USE YOUR INSTANYL SINGLE-DOSE NASAL SPRAY

Medications. Managing and Administering Medication

Caring for a person with a stoma and dementia

Homely Remedies Guidance

Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes

Network Guidance for Handling the Spillage of Cytotoxic and Anti-Cancer Drug

Case scenarios: Patient Group Directions

Community Pharmacy Enhanced Service. Just In Case 4 Core Drugs supply. Stock Holding of Palliative Care Medicines

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. N FENTANYL PATCH Fentanyl Transdermal Patches (Matrix)

Unit 204 Assist with the assembly of prescribed items

SCHEDULE 2 THE SERVICES

Patient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes

questions about why this medicine has been prescribed for you.

You have high risk feet

Procedure Reviewed By: Narinder Sangha Deputy Chief Pharmacist STANDARD OPERATING PROCEDURE

Radical Orchidectomy. Department of Urology. Patient Information

Before you use DENPAX. When you must not use it

Qutenza (Capsaicin) 8% patch

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS

Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure

Coversheet for Network Site Specific Group Agreed Documentation

PART III: CONSUMER INFORMATION ABOUT THIS MEDICATION. APO-FENTANYL MATRIX fentanyl transdermal system

Best Practice Guidance 12_Version 1.2. Title: Collection of Biological Samples

Radiotherapy treatment to your breast buds

Package leaflet: Information for the user. Qutenza 179 mg cutaneous patch capsaicin

Medicines for Self Care Policy

Latex and Occupational Dermatitis Policy Incorporating Glove Selection

Dabrafenib (Tafinlar )

A patient guide to the use of insulin for diabetes

Summary of Product Characteristics

Patient Group Directions Policy

The Safe Collection and Disposal of Drug Related Litter in the Community

Nitro-Dur 0.2 mg/h, 0.4 mg/h, 0.6 mg/h Transdermal Patch Glyceryl trinitrate

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the

TOP TIPS NHS COMMUNITY PHARMACY FLU VACCINATION SERVICE

Where do you get most of your information about medications?

Information and instruction for Home Helps caring for clients with indwelling urinary catheters

Coping with tummy bugs. Advice for parents/carers on dealing with an episode of diarrhoea and/or vomiting

Package leaflet: Information for the user. Fetanex 12.5 microgram/hour Transdermal Patch Fetanex 37.5 microgram/hour Transdermal Patch.

questions about why this medicine has been prescribed for you.

Shropshire s Continence Advisory Service INDWELLING URINARY CATHETERS

PATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system)

Cataract Surgery Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives

2.2 Blood sampling can be done for various tests depending on the clinical research study.

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services

What is a Leaderflex catheter?

CONSENT FORM UROLOGICAL SURGERY

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016

Date First Issued: Date of Last Review: Date of Next Review: Version Number: 1.0

Endovenous ablation treatment of varicose veins under local anaesthetic

MRSA. Meticillin Resistant Staphylococcus aureus. Infection Control Department. Royal Surrey County Hospital. Patient information leaflet

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS

North of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines

Catheter Passport. Guide for male and female patients and their carers. Please keep it safe.

Medicines which should not be regularly prescribed in primary care. Consultation. Information booklet

Users of this standard will need to ensure that practice reflects up-to-date information and policies.

POLICY MEDICAL POLICY RE: INFECTION CONTROL. This policy applies to all School departments, including EYFS

Fencino patch (5) 2. Check the practice has agreed to the protocol and a signed copy is in place.

Transcription:

Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG Introduction This procedure is intended to encourage good practice in the management of opioid transdermal patches to ensure that they are correctly stored correctly, administered, recorded and disposed of. These opioids patches are strong opioids e.g fentanyl and buprenorphine. They are available as a self adhesive patch. This allows a standard amount of drug to cross each hour from the patch into the skin and provides a continuous delivery of drug into the body over the duration administration period. All health and social care organisations are accountable for ensuring the safe management of controlled drugs (CD s) within care homes. Organisation within which the SOP applies: All Care homes receiving medicines from community pharmacies and/or whose service users are registered with GP practices within NHS Sutton CCG Objectives / Purpose To ensure that opioid transdermal patches are administered correctly and the administration appropriately witnessed according to CD procedure 26. To ensure that opioid transdermal patches are received, stored, handled and disposed of correctly To ensure w r i t t e n records of all opioids transdermal patch products received, administered and disposed of, are made and kept in a suitable register within the home. To define accountability and responsibilities of individual members and to ensure practice is in line with the regulatory frameworks Scope This Standard Operating Procedure applies to Managers, Nurses and care staff working within Care Homes in NHS Sutton CCG who have responsibility for medicines Responsibilities Staff working in the areas who have a responsibility for the safer management of medicines in care homes within NHS Sutton CCG Related Guidelines and Standing Operational Procedures NHS Oxfordshire Guidelines on the use of Transdermal Fentanyl Patches and NHS Blackburn and Darwen The use of fentanyl patches for severe chronic pain guidance for care homes and domiciliary care. Regulation 13 of the Health and Social Care Act 2008 (Regulated Activities 2009) Regulation 2010 THE HANDLING OF MEDICINES IN SOCIAL CARE Royal Pharmaceutical Society November 2007 The Health and Social Care Act 2008 (regulated activities) Regulations 2014. Safe Care and treatment. Regulation 12 NHS PrescQIPP Bulletin 75: Guidelines on the management of controlled drugs (CD) in care homes: December 2014 Review Period

January 2019 (or earlier if indicated) Validation process: This guidance has been approved by Sutton and Merton MMC for use in care homes within NHS Sutton Clinical Commissioning Group Author and contributors: Hai To, Care Home Pharmacist, NHS Sutton CCG Acknowledgement: Tania Cook, Specialist Senior Medicines Management Technician Social Care Lead, NHS Nottingham City CCG Date Approved: January 2017

Process Actions There are currently 2 different opioids available as transdermal patches. They are fentanyl and buprenorphine. Fentanyl and buprenorphine are CDs and their use must be entered the CD register and stock must be stored in an approved CD cabinet. Further information on controlled drugs is available in Care Home Procedure 26 - Controlled Drugs It is important that disposable gloves are worn by staff applying patches as fentanyl and buprenorphine are extremely potent painkillers, and it is important that staff do not absorb any of the drugs through their skin. The patch should be applied to a clean, dry area of skin which is non hairy; if necessary, the hair may be clipped with scissors but not shaved. Do not apply the patch to irritated, recently irradiated or shaven skin, or on lymphoedematous areas. Press in place firmly with the palm of the hand for 30 seconds. Some patients may need a semi-permeable dressing to ensure adherence. If more than one patch is applied they should be applied at the same time and placed far enough apart so they do not overlap. Refer to the patient information leaflet (PIL) for information as to where the patch may be applied. Service users can bathe or shower (with care) whilst wearing a patch but the water should not be too hot. When a new patch is to be applied, it should not be applied immediately after a bath or a shower or immediately after using creams, talc or soap on the skin. The skin should be completely dry before application of the patch. Remove the old patch before applying a new one. The new patch should be dated and a patch chart used to indicate the date and position of the patch on the resident so that sites can be rotated. It should also be clear on the MAR chart when a service user s patch should be changed Ensure all patches are removed prior to the application of a new patch - it is important to remember that some drug remains in the patch after the duration period specified e.g. 72 hours has elapsed. Overdose may occur if patches are not removed appropriately Ideally the underlying skin should be allowed to rest for 3-6 days before applying another patch to the same area. The site of application should be rotated in accordance with the manufacturer s guidance The patch should be checked each day to ensure that it is still in place. Heat (e.g. hot baths, electric blankets, hot water bottles) should NEVER be applied over the top of the patch as it may enhance the absorption of these drugs and therefore cause the Responsible Person Designated nurse (for nursing clients) or Home Manager/Senior Carer

patient to receive a higher dose An increased temperature / fever may also increase absorption and the resident should be monitored for side effects and toxicity. Seek advice from the service user s GP. Site irritation, usually from the adhesive, may necessitate a change of brand and should be discussed with the service user s GP When ordering repeat opioid patches, it is important to ensure the service user has enough for continued therapy but it is also important not to over-order the patches as the dosage of the patch may need to be changed Used patches still contain the drug, therefore it is important to ensure these are disposed off correctly as described below: After removal, fold the patch in half and stuck together with the adhesive sides inwards discard in a sharps bin or, for care homes without nursing, they should return to the supplying pharmacy for destruction Remove gloves and wash hands thoroughly Any unused patches should also be disposed of appropriately in line with the care homes medicines waste disposal procedure 18.

Appendix 1: Patch application record Name of resident Date of birth Drug name: Strengths(s): No. of patches: DAY DATE TIME ACTION/COMMENT SIGNATURES 1 2 3 4 5 6 7 Drug name: Strengths(s): No. of patches: 1 2 3 4 5 6 7

The old patch should be removed before applying the new patch. The old patch must be folded in half and stuck together before disposal. The site of application should be rotated in accordance with the manufacturer guidance. Use a cross (x) to indicate where the new patch has been applied. Use a new section each time patches are applied. The patch should be checked on a daily basis to make sure it is still in place.

I have read and understood this standard operating procedure and agree to work to it. Name Job Title Signature Date Home Manager